NGM Biopharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
NGM Biopharmaceuticals Inc
CIK #0001426332
EDGAR Form CIK 2011 - 2025
10-K [0001426332]
10-Q [0001426332]
3 [0001426332]
4 [0001426332]
8-K [0001426332]
D [0001426332]
SC 13D [0001426332]
SC 13G [0001426332]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc NGM Biopharmaceuticals Inc [2023-02-09]
BlackRock Inc NGM Biopharmaceuticals Inc [2023-02-03]
EcoR1 Capital LLC NGM Biopharmaceuticals Inc [2022-10-28]
Rho Ventures V LP NGM Biopharmaceuticals Inc [2020-02-11]
Topspin Fund LP NGM Biopharmaceuticals Inc [2019-11-26]
Column Group L P NGM Biopharmaceuticals Inc [2019-04-12]
Merck & Co Inc NGM Biopharmaceuticals Inc [2019-04-09]
Form 3/4/5 Subject 2011 - 2025
NGM Biopharmaceuticals Inc
Viret Jean-Frederic
Woodhouse David J
TCG Opportunity III GP, LLC
Column Group Opportunity III, LP
Column Group III-A LP
Column Group III GP LP
Column Group IV, LP
Column Group IV GP, LP
TCG IV GP LLC
Column Group III LP
Column Group GP LP
Column Group Opportunity III GP, LP
Column Group IV-A, LP
Column Group II LP
Svennilson Peter
Ponoi Capital LP
Ponoi Capital II, LP
Kutzkey Tim
Column Group II GP, LP
Ponoi Management, LLC
Ponoi II Management, LLC
Column Group Management LP
Column Group L P
Goeddel David V
Lieu Hsiao D
Perlmutter Roger M
Rieflin William JL
Hooper Suzanne Sawochka
Guyer Shelly D
Ho Carole
Perlich Irene
Pierce Valerie L
Nolan Mangini Siobhan
Chen Jin-Long
Leschly Mark
Schnell David
Tichenor McHenry T
Trombley Aetna Wun
Merck Sharp & Dohme Corp.
Merck & Co., Inc.
Terms | Privacy | Guide
tony@aum13f.com